California Biomedical Industry PAC, Sponsored by California Heathcare Institute
A - OTH
$445.4K
Total received
163
Donations
59
Unique contributors
$2.7K
Avg donation
Years active: 2010, 2009
Top Contributions
| Date | Contributor | Type | Amount |
|---|---|---|---|
| Jan 12, 2010 | Amylin Pharmaceuticals | OTH | $6,500 |
| Jun 15, 2010 | Johnson & Johnson Services, Inc. | OTH | $6,500 |
| Jan 12, 2010 | Medtronic, Inc. | OTH | $6,500 |
| Dec 31, 2010 | Medtronic, Inc. | OTH | $6,500 |
| Dec 31, 2010 | Genentech | OTH | $6,500 |
| Mar 2, 2010 | Biogen Idec | OTH | $6,500 |
| Jan 19, 2010 | Gen-Probe Incorporated | OTH | $6,500 |
| Feb 16, 2010 | Amgen | OTH | $6,500 |
| Feb 5, 2010 | Gilead Sciences Inc | OTH | $6,500 |
| Jan 19, 2010 | Gen-Probe Incorporated | OTH | $6,500 |
| Feb 5, 2010 | Gilead Sciences Inc | OTH | $6,500 |
| Feb 16, 2010 | Amgen | OTH | $6,500 |
| Jan 12, 2010 | Medtronic, Inc. | OTH | $6,500 |
| Mar 2, 2010 | Biogen Idec | OTH | $6,500 |
| Jan 12, 2010 | Amylin Pharmaceuticals | OTH | $6,500 |
| Jun 24, 2009 | Abbott Laboratories | OTH | $6,500 |
| Jan 12, 2010 | Amylin Pharmaceuticals | OTH | $6,500 |
| Dec 1, 2009 | ResMed, Inc. | OTH | $6,500 |
| Dec 1, 2009 | NuVasive, Inc. | OTH | $6,500 |
| Jun 24, 2009 | Abbott Laboratories | OTH | $6,500 |
| May 4, 2010 | Allergan | OTH | $6,500 |
| Mar 2, 2010 | Biogen Idec | OTH | $6,500 |
| Feb 16, 2010 | Amgen | OTH | $6,500 |
| Dec 1, 2009 | NuVasive, Inc. | OTH | $6,500 |
| Dec 1, 2009 | ResMed, Inc. | OTH | $6,500 |
| Feb 5, 2010 | Gilead Sciences Inc | OTH | $6,500 |
| Jan 19, 2010 | Gen-Probe Incorporated | OTH | $6,500 |
| Jan 12, 2010 | Medtronic, Inc. | OTH | $6,500 |
| Dec 16, 2010 | Edwards Lifesciences | OTH | $6,500 |
| Feb 17, 2009 | Gilead | OTH | $6,000 |
| Dec 10, 2009 | Genentech | OTH | $6,000 |
| Dec 23, 2009 | Edwards Lifesciences | OTH | $6,000 |
| Jan 12, 2009 | Edwards Lifesciences | OTH | $6,000 |
| Jan 19, 2009 | Gen-Probe Incorporated | OTH | $6,000 |
| Jan 21, 2009 | Genentech | OTH | $6,000 |
| Jan 27, 2009 | Amgen | OTH | $6,000 |
| Feb 3, 2009 | Johnson & Johnson Services, Inc. | OTH | $6,000 |
| Feb 17, 2009 | Allergan | OTH | $6,000 |
| Feb 17, 2009 | Biogen Idec | OTH | $6,000 |
| Feb 17, 2009 | Gilead | OTH | $6,000 |
| Dec 10, 2009 | Genentech | OTH | $6,000 |
| Dec 23, 2009 | Edwards Lifesciences | OTH | $6,000 |
| Jan 12, 2009 | Edwards Lifesciences | OTH | $6,000 |
| Jan 19, 2009 | Gen-Probe Incorporated | OTH | $6,000 |
| Jan 21, 2009 | Genentech | OTH | $6,000 |
| Jan 27, 2009 | Amgen | OTH | $6,000 |
| Feb 3, 2009 | Johnson & Johnson Services, Inc. | OTH | $6,000 |
| Feb 17, 2009 | Allergan | OTH | $6,000 |
| Feb 17, 2009 | Biogen Idec | OTH | $6,000 |
| May 12, 2009 | Pfizer, Inc | OTH | $4,000 |
| May 12, 2009 | Pfizer, Inc | OTH | $4,000 |
| Apr 7, 2009 | AstraZeneca | OTH | $3,000 |
| Jan 19, 2010 | MedImmune, Inc | OTH | $3,000 |
| Jan 12, 2010 | Thermo Fisher Scientific, Inc. | OTH | $3,000 |
| Jan 21, 2009 | Eli Lilly and Company | OTH | $3,000 |
| Jan 19, 2010 | MedImmune, Inc | OTH | $3,000 |
| Feb 3, 2009 | MedImmune | OTH | $3,000 |
| Jan 19, 2010 | MedImmune, Inc | OTH | $3,000 |
| Jan 12, 2010 | Thermo Fisher Scientific, Inc. | OTH | $3,000 |
| Apr 7, 2009 | AstraZeneca | OTH | $3,000 |
| Jan 12, 2010 | Thermo Fisher Scientific, Inc. | OTH | $3,000 |
| Feb 3, 2009 | MedImmune | OTH | $3,000 |
| Jan 21, 2009 | Eli Lilly and Company | OTH | $3,000 |
| Mar 31, 2009 | Amylin Pharmaceuticals | OTH | $2,750 |
| Mar 31, 2009 | Amylin Pharmaceuticals | OTH | $2,750 |
| Jan 19, 2010 | St. Jude Medical | OTH | $2,750 |
| Jan 19, 2010 | St. Jude Medical | OTH | $2,750 |
| Jan 19, 2010 | St. Jude Medical | OTH | $2,750 |
| Dec 31, 2010 | St. Jude Medical | OTH | $2,750 |
| Dec 22, 2009 | Elan Pharmaceuticals | OTH | $2,250 |
| Dec 22, 2009 | Elan Pharmaceuticals | OTH | $2,250 |
| Sep 8, 2010 | Novartis Vaccines & Diagnostics | OTH | $2,250 |
| Jan 12, 2010 | Exelixis, Inc | OTH | $2,050 |
| Jan 12, 2010 | Exelixis, Inc | OTH | $2,050 |
| Jan 12, 2010 | Exelixis, Inc | OTH | $2,050 |
| Jun 1, 2010 | Pfizer, Inc | OTH | $2,000 |
| Dec 15, 2009 | Align Technology, Inc. | OTH | $1,850 |
| Dec 31, 2010 | Align Technology, Inc. | OTH | $1,850 |
| Dec 15, 2009 | Align Technology, Inc. | OTH | $1,850 |
| Apr 14, 2009 | Elan Pharmaceuticals | IND | $1,575 |
| Apr 14, 2009 | Elan Pharmaceuticals | IND | $1,575 |
| Mar 2, 2010 | Onyx Pharmaceuticals Inc | OTH | $1,425 |
| Apr 6, 2010 | BioMarin | OTH | $1,425 |
| Jan 19, 2009 | Nektar Therapeutics | OTH | $1,425 |
| Mar 2, 2010 | Onyx Pharmaceuticals Inc | OTH | $1,425 |
| Jan 19, 2009 | Nektar Therapeutics | OTH | $1,425 |
| Apr 6, 2010 | BioMarin | OTH | $1,425 |
| Mar 2, 2010 | Onyx Pharmaceuticals Inc | OTH | $1,425 |
| Apr 6, 2010 | BioMarin | OTH | $1,425 |
| Jan 19, 2009 | CV Therapeutics | OTH | $1,300 |
| Jan 19, 2009 | CV Therapeutics | OTH | $1,300 |
| Jan 19, 2009 | Exelixis | OTH | $1,300 |
| Jan 19, 2009 | Exelixis | OTH | $1,300 |
| Jun 1, 2010 | Zimmer | OTH | $1,213 |
| Dec 31, 2010 | Genomic Health, Inc. | OTH | $1,025 |
| Mar 16, 2010 | Volcano Corporation | OTH | $1,025 |
| Mar 16, 2010 | Volcano Corporation | OTH | $1,025 |
| Mar 16, 2010 | Volcano Corporation | OTH | $1,025 |
| Jan 12, 2010 | Price Waterhouse Coopers | OTH | $1,000 |
| Jan 12, 2010 | Price Waterhouse Coopers | OTH | $1,000 |
| Feb 16, 2010 | Xoma LLC | OTH | $1,000 |
| Jan 12, 2010 | Price Waterhouse Coopers | OTH | $1,000 |
| Jan 19, 2009 | Price Waterhouse Coopers | OTH | $1,000 |
| Jan 19, 2009 | Price Waterhouse Coopers | OTH | $1,000 |
| Feb 16, 2010 | Xoma LLC | OTH | $1,000 |
| Feb 17, 2009 | Xoma LLC | OTH | $1,000 |
| May 3, 2010 | Pfizer, Inc | OTH | $1,000 |
| Feb 16, 2010 | Xoma LLC | OTH | $1,000 |
| Feb 17, 2009 | Xoma LLC | OTH | $1,000 |
| Feb 4, 2010 | Celera Diagnostics | OTH | $650 |
| Jul 6, 2010 | Isis Pharmaceuticals | OTH | $650 |
| Feb 4, 2010 | Celera Diagnostics | OTH | $650 |
| Feb 4, 2010 | Celera Diagnostics | OTH | $650 |
| Jan 12, 2009 | Hogan & Hartson | OTH | $500 |
| Jan 5, 2009 | IMS Health | OTH | $500 |
| Jan 5, 2009 | Fenwick & West LLP | OTH | $500 |
| Dec 23, 2009 | Edwards Lifesciences | OTH | $500 |
| Dec 10, 2009 | Genentech | OTH | $500 |
| Mar 16, 2010 | Synteract | OTH | $500 |
| Dec 1, 2009 | MDV-Mohr Davidow Ventures | OTH | $500 |
| Dec 1, 2009 | Hogan & Hartson LLP | OTH | $500 |
| Nov 9, 2009 | Monitor Group | OTH | $500 |
| Aug 11, 2009 | Alta Partners | OTH | $500 |
| Aug 11, 2009 | Alta Partners | OTH | $500 |
| Dec 1, 2009 | MDV-Mohr Davidow Ventures | OTH | $500 |
| Sep 7, 2010 | IMS Health | OTH | $500 |
| Sep 21, 2010 | Knobbe Martens Olson & Bear LLP | OTH | $500 |
| Mar 16, 2010 | Synteract | OTH | $500 |
| Jan 12, 2009 | Hogan & Hartson | OTH | $500 |
| Dec 23, 2009 | Edwards Lifesciences | OTH | $500 |
| Jan 5, 2009 | IMS Health | OTH | $500 |
| Jan 5, 2009 | Fenwick & West LLP | OTH | $500 |
| Jun 15, 2010 | Alexandria Real Estate Equities | OTH | $500 |
| Dec 10, 2009 | Genentech | OTH | $500 |
| Nov 9, 2009 | Monitor Group | OTH | $500 |
| Mar 16, 2010 | Synteract | OTH | $500 |
| Dec 1, 2009 | Hogan & Hartson LLP | OTH | $500 |
| Nov 15, 2010 | MedImmune, Inc | OTH | $326.25 |
| Sep 27, 2010 | DexCom Inc | OTH | $275 |
| Jan 5, 2009 | Affymax, Inc. | OTH | $275 |
| Jan 19, 2010 | Cepheid | OTH | $275 |
| Dec 31, 2010 | BN ImmunoTherapeutics | OTH | $275 |
| Dec 31, 2010 | Cepheid | OTH | $275 |
| Dec 15, 2009 | ISTA Pharmaceuticals | OTH | $275 |
| May 17, 2010 | Theravance, Inc | OTH | $275 |
| Dec 31, 2010 | The Foundry LLC | OTH | $275 |
| Jan 19, 2010 | Cepheid | OTH | $275 |
| Jan 19, 2010 | Cepheid | OTH | $275 |
| Jan 5, 2009 | Affymax, Inc. | OTH | $275 |
| Dec 15, 2009 | ISTA Pharmaceuticals | OTH | $275 |
| Jan 19, 2009 | ISTA Pharmaceuticals | OTH | $275 |
| Jan 19, 2009 | ISTA Pharmaceuticals | OTH | $275 |
| Apr 20, 2010 | Rigel Pharmaceuticals, Inc | OTH | $171 |
| Apr 20, 2010 | Rigel Pharmaceuticals, Inc | OTH | $171 |
| Apr 20, 2010 | Rigel Pharmaceuticals, Inc | OTH | $171 |
| Jan 27, 2009 | Rigel, Inc | OTH | $139 |
| Jan 27, 2009 | Rigel, Inc | OTH | $139 |
| Dec 18, 2009 | Proteus Biomedical | OTH | $50 |
| Dec 3, 2009 | Alexza Pharmaceuticals | OTH | $50 |
| Dec 1, 2009 | Sangamo BioSciences, Inc | OTH | $50 |
| Dec 3, 2009 | Alexza Pharmaceuticals | OTH | $50 |
| Dec 1, 2009 | Sangamo BioSciences, Inc | OTH | $50 |
| Dec 18, 2009 | Proteus Biomedical | OTH | $50 |